Article: Immunome Inc. Presenting Human Monoclonal Antibody Platform at Pharmaceutical Consulting Consortium, INC. (PCCI).

Immunome, Inc., President and CEO, Tim Pelura, Ph.D., will be presenting information about the company on Monday, November 9, 2009 at the Pharmaceutical Consulting Consortium, Inc. (PCCI) Meeting. The presentation will be also be available for viewing via webcast at www.rxpcci.com (see also Infectious Diseases).

Immunome is a start-up biopharmaceutical company located in the biotechnology incubator at the Lankenau Institute for Medical Research in Wynnewood, PA. Immunome has a proprietary technology for cloning "native" human antibodies (N-huMAbs), high-affinity IgG antibodies that maintain the exact, protective configurations created by the healthy human immune ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!